The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US9181249, 138 ID: ALA3958294
PubChem CID: 118159271
Max Phase: Preclinical
Molecular Formula: C21H34N6O3
Molecular Weight: 418.54
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)N1CCc2nc(N3CCN(C(=O)OC(C)(C)C)CC3)c(NC(C)C)nc2C1
Standard InChI: InChI=1S/C21H34N6O3/c1-14(2)22-18-19(24-16-7-8-27(15(3)28)13-17(16)23-18)25-9-11-26(12-10-25)20(29)30-21(4,5)6/h14H,7-13H2,1-6H3,(H,22,23)
Standard InChI Key: CJEZYFCOYOMTCD-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 32 0 0 0 0 0 0 0 0999 V2000
4.9395 -1.3433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8990 -0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8969 0.4545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6003 -1.4977 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2991 3.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -3.0008 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2978 -3.7529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2955 -5.2529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0048 -6.0009 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3026 -5.2488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3002 -3.7488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0102 -7.5017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0270 -8.1051 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3123 -8.2482 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3177 -9.7490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3588 -10.3459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3215 -10.9490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2805 -10.3525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3022 5.2508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3422 5.8493 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.2640 5.8526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 7 2 0
12 13 1 0
13 14 2 0
14 5 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 15 1 0
18 21 1 0
21 22 2 0
21 23 1 0
23 24 1 0
24 25 1 0
24 26 1 0
24 27 1 0
9 28 1 0
28 29 2 0
28 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 418.54Molecular Weight (Monoisotopic): 418.2692AlogP: 2.26#Rotatable Bonds: 3Polar Surface Area: 90.90Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.41CX LogP: 1.15CX LogD: 1.15Aromatic Rings: 1Heavy Atoms: 30QED Weighted: 0.81Np Likeness Score: -1.27
References 1. (2015) Substituted pyrido[3,4-b]pyrazines as GPR6 modulators, 2. (2018) Tetrahydropyridopyrazines modulators of gpr6, 3. (2016) Tetrahydropyridopyrazines modulators of gpr6,